Showing results (1461-1470 of 4,599) with videos related to
Sort By:
Pageof 460
Chemmedchem|August 8, 2006
An accurate and interpretable bayesian classification model for prediction of HERG liabilityHongmao SunChemmedchem|August 8, 2006
A PEG-based biocompatible block catiomer with high buffering capacity for the construction of polyplex micelles showing efficient gene transfer toward primary cellsNaoki Kanayama, Shigeto Fukushima, Nobuhiro Nishiyama, et al.Chemmedchem|August 8, 2006
Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapyYongdoo Choi, Jason R McCarthy, Ralph Weissleder, et al.Chemmedchem|August 8, 2006
Poly(ADP-ribose)-polymerase-catalyzed hydrolysis of NAD+: QM/MM simulation of the enzyme reactionDaniele Bellocchi, Gabriele Costantino, Roberto Pellicciari, et al.Chemmedchem|August 8, 2006
Ligand-based virtual screening, parallel solution-phase and microwave-assisted synthesis as tools to identify and synthesize new inhibitors of mycobacterium tuberculosisFabrizio Manetti, Matteo Magnani, Daniele Castagnolo, et al.Chemmedchem|August 12, 2006
Integrated approach using protein and ligand information to analyze selectivity- and affinity-determining features of carbonic anhydrase isozymesAlexander Hillebrecht, Claudiu T Supuran, Gerhard KlebeChemmedchem|August 12, 2006
The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist boundJoyce Yao-chun Peng, Nagarajan Vaidehi, Spencer E Hall, et al.Chemmedchem|August 18, 2006
Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptorStefania De Luca, Michele Saviano, Raffaella Della Moglie, et al.Chemmedchem|September 27, 2006
Diacetyldiamidoximeester of pentamidine, a prodrug for treatment of protozoal diseases: synthesis, in vitro and in vivo biotransformationBernd Clement, Anja Bürenheide, Wolfgang Rieckert, et al.Chemmedchem|September 5, 2006
Determination of the bound conformation of a competitive nanomolar inhibitor of mycobacterium tuberculosis type II dehydroquinase by NMR spectroscopyVerónica F V Prazeres, Cristina Sánchez-Sixto, Luis Castedo, et al.Pageof 460